HYPERKINETIC PULMONARY HYPERTENSION
Since pulmonary artery pressure is the product of pulmonary vascular resistance and cardiac output, any increase in pulmonary blood flow is invariably associated with an increase in pulmonary artery pressure. If the increased flow is sustained,as in intracardiac shunts, anatomical changes occur in the pulmonary vessels (vascular remodeling) which increase vascular resistance and further increase pulmonary artery pressure, causing the pulmonary hypertension to persist even after the initial stimulus is corrected. Remodeling consists initially of the muscularization and hypertrophy of previously unmuscularized small arteries, followed by medial hypertrophy and intimal proliferation in the larger pulmonary arteries. Both of these changes are reversible if the pulmonary hypertension is reduced. However, persistently high pressures produce permanent obstructive changes such as necrotizing arteritis and complex dilatations known as plexiform lesions.
- Nephrotic Glomerulopathies
- Diet
- Clinical Manifestations
- Specific Etiologies
- Aminoaciduria
- HEMODIALYSIS AND HEMOPERFUSION IN THE TREATMENT OF DRUG OVERDOSES
- CLINICAL MANIFESTATIONS OF ENDSTAGE RENAL DISEASE
- NONATHEROSCLEROTIC CAUSES OF CORONARY ARTERY OBSTRUCTION
- Tocainide
- AORTIC ARTERITIS
- GASTROESOPHAGEAL REFLUX DISEASE
- Hematopoietic System
- Alterations in Glomerular Hemodynamics, Parathyroid Hormone Metabolism, and Systemic Arterial Blood Pressure
- VENTRICULAR RHYTHM DISTURBANCES
- Texas MedicareRX
- Restrictive Cardiomyopathy
- NORMAL ESOPHAGEAL PHYSIOLOGY
- Nephrogenic Diabetes Insipidus (NDI)
- Diagnosis
- FACTORS AFFECTING THE RATE OF LOSS OF NEPHRONS
- Liver Failure
- Renal Tubular Acidosis
- Hepatorenal Syndrome
- PATHOPHYSIOLOGY OF ISCHEMIC HEART DISEASE
- DIFFUSE INFILTRATIVE DISEASES OF THE LUNG
- Indications for Dialysis and Adequacy of Dialysis
- ORIGIN OF ABDOMINAL PAIN
- CYSTIC FIBROSIS
- Gastrointestinal Tract
- AORTIC DISEASE - AORTIC ANEURYSMS
- LIVER ABSCESS
- OXYGEN
- Renal Glycosuria
- Private provider loses NHS deal
- CONTROL OF BREATHING IN DISEASE STATES